Table 2 Variables of the two groups before operation
Variables | Group A (n = 119) | Group B (n = 128) | P value |
|---|---|---|---|
Comorbidities | |||
COPD (n, %) | 9 (7.6%) | 7 (5.5%) | 0.50 |
Chronic gastritis or duodenitis (n, %) | 3 (2.5%) | 5 (3.9%) | 0.72 |
Hypertension (n, %) | 27 (22.7%) | 28 (21.9%) | > 0.99 |
Diabetes (n, %) | 15 (12.6%) | 21 (16.4%) | 0.40 |
CVD (n, %) | 6 (5.0%) | 8 (6.3%) | 0.68 |
Hemoglobin (g/dL, median, IQR) | 122 (109–133) | 121 (108–137) | 0.83 |
Serum bilirubin (mg/L, median, IQR) | 34 (12–142) | 26 (11–146) | 0.93 |
ALT (IU, median, IQR) | 50 (18–128) | 32 (15–100) | 0.40 |
Serum albumin (g/L, median, IQR) | 39 (35–43) | 38 (33–41) | 0.12 |
White blood cell count (n × 109/L, median, IQR) | 5.6 (4.5–6.9) | 5.5 (4.5–6.7) | 0.81 |
Tumor location | |||
DCBD (n, %) | 18 (15.1%) | 27 (21.1%) | 0.23 |
Pancreas (n, %) | 67 (56.3%) | 64 (50.0%) | 0.32 |
Ampulla (n, %) | 11 (9.3%) | 6 (4.7%) | 0.16 |
Duodenum (n, %) | 23 (19.3%) | 31 (24.2%) | 0.35 |